Kaken Pharmaceutical

Shares of Corbus Pharmaceuticals Holdings Inc (NASDAQ: CRBP), a clinical-stage pharmaceutical company that focuses on therapies to treat inflammatory and fibrotic diseases, gained more than 5 percent Thursday after the company announced a new strategic collaboration. What Happened Corbus said...